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Abstract 
Based on the alignment of 7 known amino acid sequences, including the recently determined sequences for the mouse and human 
enzymes, a highly conserved acidic domain was identified which in the Escherichia coli enzyme is located close to the C-terminal end of 
the predicted NADP(H)-binding site of the /3 subunit. The effect of replacing the four conserved acidic residues, /3E361, /3E374, 
/3D383 and /3D392, in this domain on catalytic and proton-pumping activity was tested by site-directed mutagenesis. In addition, 
/3E371, which is not conserved but located in the same domain, was also mutated. Of these residues, /3Asp 392 proved to be the only 
residue which is essential for both activities. However, two /3Asp 392 mutants were still partly active in catalyzing the cyclic reduction of 
3-acetylpyridine-NAD ÷ by NADH in the presence of NADPH, suggesting that the mutations did not cause a global change but rather a 
subtle local change influencing the dissociation of NADP(H). It is proposed that /3Asp 392 together with the previously identified 
/3 His91 form part of a proton wire in transhydrogenase. 
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Nicotinamide nucleotide transhydrogenase is a redox- 
driven proton pump localized in the inner membrane of 
mitochondria and the plasma membrane of certain bacteria, 
which catalyzes the reversible reduction of NADP ÷ by 
NADH and the concomitant ranslocation of 1 proton 
according to Eq. 1 
Ho+t + NADH + NADP+~ Hi + + NAD++ NADPH ( I )  
where 'out' and 'in' denote the intermembrane space and 
matrix, respectively, in mitochondria nd the periplasmic 
space and cytosol, respectively, in bacteria. In Escherichia 
coli the enzyme is composed of an a subunit (54 kDa) 
and a /3 subunit (48 kDa), the active form being o~ 2 [3  2 . 
The gene of the enzyme has been cloned and its DNA 
sequenced, and the catalytic and proton-pumping proper- 
ties of the purified and reconstituted enzyme have been 
characterized extensively. Likewise, other transhydro- 
genases and their genes from, for example, bovine heart 
and Rhodospirillum rubrum have also been characterized. 
Fig. 1 shows a schematic model of the E. coli transhydro- 
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genase (Fig. 1A) and the three major domains (Fig. 1B) of 
this enzyme (for reviews see [1,2]). 
Based on prediction of the membrane structure of the 
bovine and E. coli enzymes and subsequent mutagenesis 
of conserved charged residues in the latter transhydro- 
genase, a single basic residue, /3His91, located in the 
middle of a membrane c~ helix, was found to be important 
but not essential for catalysis and proton pumping [3,4]. 
Thus, of several mutants, /3H91K, /3H91N, /3H91T and 
flH91S as well as acidic mutants, were partially active in 
both catalysis and proton pumping [4]. It was therefore 
concluded that, even though /3His91 probably constitutes 
part of a proton-conducting wire, its function may be 
partially replaced by other charged or hydrophilic residues, 
Most other proton pumps have two or more 
hydrophilic/charged, usually negative, residues that are 
assumed to form part of a proton wire [5,6]. At least one of 
these residues, e.g., Asp96 in bacteriorhodopsin [5] and 
Asp135 in cytochrome bo [6], is located in a more hy- 
drophilic domain close to the membrane surface. The 
possible existence of a similar residue in transhydro- 
genases has not been considered or demonstrated previ- 
ously. 
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Fig. 1. Schematic presentation f the proton-pumping E. coli transhydro- 
genase (A) and the three major domains of the enzyme (B). 
The recent cloning and sequencing of the mouse and 
human transhydrogenase g nes have provided important 
additions to the existing transhydrogenase sequence infor- 
mation and identification of possible conserved residues 
essential for catalysis and proton pumping. Alignment of 
all seven known amino acid sequences of transhydro- 
genases from different organisms/species show that the 
overall identify is relatively low (not shown). However, in 
addition to the substrate-binding domains [1], other do- 
mains show a considerable identity. One of these domains 
comprises residues /3351-420 (Fig. 2), which are located 
immediately downstream the proposed NADP(H)-binding 
site in the sequence /3314-340. This domain is not homol- 
ogous to any other known amino acid sequence and is 
clearly located in a soluble region, relatively far from the 
sequence that has been predicted to constitute the last 
transmembrane c~ helix [3,7], approximately residues 
/3241-262. Among residues /3351-420 are four fully 
conserved acidic residues, i.e., /3E361, /3E374, /3D383 
and /3 D392, and two semiconserved acidic residues, /3401 
and /3413. The only additional conserved acidic residue in 
the /3 subunit, /3D213, has previously been shown not to 
be essential [3]. 
The above-mentioned conserved acidic residues /3 E361, 
/3E374, /3D383 and /3D392, as well as /3E371 which is 
not conserved but located in the same domain, were re- 
placed by site-directed mutagenesis, and the effects of the 
mutations on various transhydrogenase activities were 
tested. E. coli  containing approximately 70-fold overex- 
pressed transhydrogenase g nes was used as source of 
enzyme. Mutagenesis and transformation of E. coli  K12 
strain TG1 with plasmid pDC21 or pSA2 carrying wild-type 
or mutated pnt  genes, and isolation of cytosolic membrane 
vesicles were carried out as described [3,8-10]. Catalytic 
and proton pumping activities were assayed as reduction of 
3-acetylpyridine-NAD ÷ (AcPyAD ÷) by NADPH at pH 
7.0 [3,8,9] and reduction of AcPyAD + by NADH in the 
presence of NADPH at pH 6.0 [10], and quenching of 
ACMA at pH 7.4 [10], respectively. Proper membrane 
insertion and folding was checked by SDS-PAGE [3]. The 
variability in the activity determinations was less than 
10%. 
Transhydrogenase mutant DNA was sequenced by the 
dideoxy chain termination method [11]. Alignment of all 
known transhydrogenase g ne sequences were carried out 
as described [12]. These sequences were the genes for the 
E. coli  (GenBank accession No. X04195), bovine mito- 
chondrial (J08392), Eimeria tenella (L07954), Rhodospir -  
i l lum rubrum (U01158), Entamoeba histolytica (V 13421), 
mouse (Z49204) and human (Z50101) transhydrogenases. 
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~351 
LPGHMNVLLA EAKVPYDIVL  EMDEINDDFA DTDTVLVIGA 
MPGQLNVLLA EAGVPYDIVL  EMDZINHDFP DTDLVLVIGA 
MPGQLNVLLA EAGVPYDIVL  EMDEINSDFP DTDLVLVIGA 
MPGQLNVLLA EAGVPYDIVL  EMDEINHDFP DTDLVLVIGA 
MPPH~WVLLA EANVPYDEVF ELEE INSSFQ TADVAFVIGA 
LPGHMNVLLA EANVPYKIVF  AMEE.AEDLENVDVAIWGA 
LPGHMNVLLA EADVPYKIVK  ~MSEVNPEMS SYDVVLWGA 
** ***** ** *** . *: * : *:** 
~411 
VLEIrWKAQNV IVFKRSMNTG YAGVQNPLFF  K~%TTHMLFGD 
VLEVWKSKQV IVMKRSLGVG YAAVDNPIFY  KPNTAMLLGD 
VLEVWKSKQV IVMKRSLGVG YAAVDNPIFY  KPNTAMLLGD 
VLEVWKSKQV IVMKRSLGVG yAAVDNPIFY  KPNTAMLLGD 
ILDVEKAGTV LF IKRSMASG YAGV~ELFF  ~ F G D  
I ID IYKAKVC VVNKRSLNQG IAAVDNPLFF  YSNTRMFLSD 
V IEAWKARRV FVLKRSMAAG YAS IENPLFH LENTRMLFGN 
:::: * *** . . . :* ** . 
$410 
NDTVNPAAQD DPKSP IAGMP 
NDTVNSAAQE DPNSI IAGMP 
NDTVNSAAQE DPNSI IAGMP 
NDTVNSAAQE DPNSI IAGMP 
NDVTNPAAKT DPSSP IYGMP 
NDTVNPIAET  DPTSPLAGMP 
NDTVNPAAL.  EPGSKISGMP 
**: :*  * :* *** 
~462 
AKASVDAI  LL AL- 
AKKTCDALQA KVRESYQK.  
AKKTC DALQA KVRESYQK • 
AKKTCDALQA KVRESYQK.  
~EQIVQ AMN. 
.KKGFEELNE E IK  
AKNTTSAVFA RVN 
Fig. 2. Conserved and semiconserved acidic residues in the /3352-420 domain of transhydrogenases. Multiple alignment of the C-terminal part of the 
/3-subunit of E. coli transhydrogenase (/3351-462) with the corresponding sequences of bovine (925-1043), mouse (925-1043), human (925-1043), R. 
rubrum (B352-B464), E. histolytica (416-527) and E. tenella (348-459) transhydrogenases. Stop codons are indicated with a dot. The alignment is 
underscored with stars for identity and colons for high similarity. Conserved and semiconserved negatively charged residues are bold. 
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Table 1 
Effects of site-specific mutation on catalytic and proton pumping activi- 
ties catalyzed by E. coli transhydrogenase 
Mutant AcPyAD÷/ Proton NADH/AcPyAD ÷ 
NADPH pumping ( + NADPH) 
activity (%) activity (%) activity (%) 
Wild type 100 100 100 
TGI 3 3 4 
/3 E361Q 20 40 113 
/3 E371Q 71 78 34 
/3 E374L 63 108 33 
/3 D383L 49 79 n.d. 
/3 D383R 92 123 n.d. 
/3 D392A 1 0 44 
/3 D392K 3 0 2 
/3 D392N 2 0 13 
/3 D392Q 3 0 2 
/3 D392T 2 0 2 
Control activities (100%) for reduction of AcPyAD ÷ by NADPH and for 
reduction of AcPyAD + by NADH in the presence of NADPH catalyzed 
by wild-type cytoplasmic membrane vesicles were 3.3 /zmol/min per mg 
protein and 8.3 /zmol/min per mg protein, respectively. Proton pumping 
was measured as initial decrease in ACMA fluorescence/min per mg 
protein expressed as % of control. 
n.d., not determined. 
Of these, the E. coli [13,14], bovine [7], Eimeria tenella 
[15], Rhodospirillum rubrurn [16,17] and Entamoeba his- 
tolytica [18] sequences have been published previously. 
The Eimeria acervulina transhydrogenase (L08392) [19] 
has only been sequenced with regard to the domain corre- 
sponding to the c~ subunit of the E. coli enzyme and is 
therefore not included in this study. The mouse and human 
transhydrogenase genes were cloned recently by our group 
(Lagberg, E. and Rydstr~Sm, J. unpublished ata). 
Activities for reduction of AcPyAD ÷ by NADPH, re- 
duction of AcPyAD ÷ by NADH in the presence of 
NADPH, and proton pumping, all catalyzed by cytosplas- 
mic membrane, were determined for the mutant trans- 
hydrogenases. As shown in Table 1, replacement of all 
residues except /3D392 resulted in active mutant trans- 
hydrogenases. Indeed, the activities of the /3 D383R and 
/3E361Q mutants were even significantly higher than con- 
trol with regard to proton pumping and reduction of 
AcPyAD ÷ by NADH in the presence of NADPH. In 
general, all active mutant transhydrogenases, i.e. /3 E361 Q, 
/3E371Q, /3E374L, /3D383L and flD383R, catalyzed 
proton pumping at a rate which apparently was proportion- 
ally higher than that for the primary reaction, reduction of 
AcPyAD + by NADPH, which is generally explained by 
the non-linearity of the proton-pumping assay. The activi- 
ties of the /3Asp392 mutants /3 D392A, /3 D392K, 
/3 D392N, /3 D392Q and /3 D392T were approximately 
0-3% of the wild-type control activity with respect o 
reduction of AcPyAD ÷ by NADPH and proton pumping, 
whereas the background activities of the genomic TG1 
transhydrogenase w re approximately 3%. Consequently, 
all /3Asp392 mutants were inactive. However, the activity 
for reduction of AcPyAD ÷ by NADH in the presence of 
NADPH was still substantial for the /3D392A and 
/3D392N mutants, i.e., 44% and 13%, respectively, but 
only 2% for the /3D392K, flD392Q and flD392T mu- 
tants. It was therefore concluded that the /3D392 mutant 
transhydrogenases were essentially inactive with regard to 
reduction of AcPyAD ÷ by NADPH and proton pumping, 
but that a partial reaction was retained to a considerable 
extent in the /3 D392A and /3 D392N mutants. 
Expression levels and folding of mutated transhydro- 
genases were tested by SDS-PAGE (cf. Ref. [3]). All 
mutants in Table 1 were equally expressed, inserted in the 
membrane and folded as compared to wild type except for 
the /3 D392K mutant which appeared to be normally ex- 
pressed but subsequently partially degraded (not shown). 
Like other proton pumps transhydrogenase pr sumably 
translocates protons through the protein by some type of 
proton wire. /3His91 located in the predicted transmem- 
brane helix 9 has previously been concluded to form part 
of a proton wire and to accept protons from the periplas- 
mic space [1,3,4,10]. Obviously, the opposite end of the 
assumed wire may be located in the cytoplasmic part of 
either the a subunit or the /3 subunit. One possibility is 
that the /3 subunit, which undergoes dramatic onforma- 
tional changes upon NADP(H) binding and proton transit- 
cation [1,2], indeed harbors the cytosolic part of the proton 
wire, and that the main function of the a subunit is to 
provide reducing equivalents for NADP ÷ bound to the /3 
subunit. 
The present results indicate that /3Asp392 is essential 
for reduction of AcPyAD ÷ by NADPH and proton pump- 
ing and that it may form part of a proton wire. The finding 
that /3Glu361, /3Glu371, /3Glu374 and flAsp383 were 
not essential for activity or proton pumping does not 
exclude that these residues participate in proton pumping, 
but rather that they are not essential, i.e., if they are 
participating in proton pumping their function may be 
shared with or replaced by other residues. This possibility 
and the roles of the semiconserved residues flAsp401 and 
flAsp 413 are being investigated. In addition to /3His91 
and /3Asp392, other conserved basic residues and/or ser- 
ine, tyrosine and threonine residues in the /3 subunit are 
being considered as components of a transhydrogenase 
proton wire. The only other essential residues identified 
earlier are aGly172 [12] and /3Gly314 [20], which both 
are essential for the structure of the /3a/3 fold of the 
NAD(H) and NADP(H)-binding sites, respectively. 
Reduction of AcPyAD ÷ by NADH at low pH in the 
presence of NADPH has been suggested to reflect a cyclic 
reaction in which NADH reduces AcPyAD ÷ via bound 
NADP(H) [1,10,21-23]. This reaction has been shown not 
to pump protons [10]. A similar reaction is catalyzed by 
the bovine enzyme [24-26]. Bound NADP(H) participating 
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in this cyclic reaction may be cellular NADP(H)  [23] or 
NADP(H)  added to the isolated enzyme [9,21-26]. Rou- 
tinely, this cyclic reaction is always catalyzed by trans- 
hydrogenases which are active in the reduction of 
AcPyAD ÷ by NADPH and proton pumping. However, the 
reverse is not always the case, i.e., if the transhydrogenase 
is modif ied in a manner which does not allow NADP(H)  to 
dissociate sufficiently rapid, the cyclic reaction may be 
active but not, or much less so, the reduction of AcPyAD + 
by NADPH or proton pumping. The present f inding that 
/3 D392A and to some extent /3 D392N, but not /3 D392K, 
/3D392Q or /3D392T, catalyzed the cyclic reaction, 
strongly suggests that the mutation did not cause a global 
change/ inact ivat ion f the transhydrogenase, but rather a 
subtle local change that inf luenced the b ind ing/d issoc ia-  
tion of NADP(H)  from its binding site. Since /3Asp392 is 
close to the predicted binding site [2], it is possible that 
this residue constitutes part of the NADP(H)  site. 
In conclusion, in a domain containing 6 acidic con- 
served/semiconserved r sidues, /3Asp392 was found to be 
essential for catalysis and proton pumping. It is proposed 
that the protonat ion/deprotonat ion state of /3Asp392, as a 
component of the transhydrogenase proton wire and possi- 
bly the NADP(H)  site, indirect ly regulates the 
associat ion/dissociat ion of NADP(H)  through a conforma- 
tional change. 
This work was supported by the Swedish Natural Sci- 
ences Research Council.  
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